DT MedTech Receives FDA Clearance for Hintermann Total Ankle

DT MedTech (DTM) received FDA 510(k) clearance to market the Hintermann Series H2™ Total Ankle Replacement, a semi-constrained cemented prosthesis for primary or revision surgery. Limited launch is slated for late 4Q17, ex-U.S., as it has already secured CE Mark Approval.

Hintermann Series H2 is also indicated to treat failed total ankle...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

Contact Us